當(dāng)前位置：上海博研生物工程研究中心>>科研抗體>>抗體>>Anti-Uteroglobin抗體,子宮珠蛋白抗體

Anti-Uteroglobin抗體,子宮珠蛋白抗體

返回列表頁(yè)

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品牌

廠商性質(zhì)代理商

所在地上海市

在線詢價(jià) 收藏產(chǎn)品查看聯(lián)系電話

聯(lián)系方式：楊洋查看聯(lián)系方式

更新時(shí)間：2018-04-16 04:23:56瀏覽次數(shù)：205次

聯(lián)系我時(shí)，請(qǐng)告知來(lái)自環(huán)保在線

產(chǎn)品分類 品牌分類

  科研抗體

FITC標(biāo)記抗體

磷酸化抗體

抗原蛋白多肽

抗體

全部產(chǎn)品列表

暫無(wú)信息

上海博研生物工程研究中心

經(jīng)營(yíng)模式：代理商

商鋪產(chǎn)品：9977條

所在地區(qū)：上海上海市

聯(lián)系人：楊洋（經(jīng)理）

詢價(jià) 給他留言

產(chǎn)品簡(jiǎn)介

Anti-Uteroglobin抗體,子宮珠蛋白抗體，規(guī)格0.1ml/0.2ml,提供，：.

詳細(xì)介紹

產(chǎn)品名稱：Anti-Uteroglobin抗體,子宮珠蛋白抗體

產(chǎn)品編號(hào)：BYK-1935R

產(chǎn)品規(guī)格：0.1ml/0.2ml

產(chǎn)品價(jià)格：請(qǐng)

此產(chǎn)品本公司有標(biāo)記的一抗出售，相關(guān)標(biāo)記有：Alexa Fluor 350 標(biāo)記、Alexa Fluor 488 標(biāo)記、Alexa Fluor 555 標(biāo)記、Alexa Fluor 647 標(biāo)記、AP標(biāo)記、APC標(biāo)記、Biotin標(biāo)記、Cy3標(biāo)記、Cy5標(biāo)記、Cy5.5標(biāo)記、Cy7標(biāo)記、FITC標(biāo)記、Gold標(biāo)記、HRP標(biāo)記、PE標(biāo)記、PE-Cy3標(biāo)記、PE-CY5標(biāo)記、PE-CY5.5標(biāo)記、PE-CY7標(biāo)記、RBITC標(biāo)記

產(chǎn)品別名：blastokinin; CC10; CC16; CCPBP; CCSP; Clara cell phospholipid binding protein; Clara cell phospholipid-binding protein; clara cell secretory protein; Clara cell specific 10 kD protein; Clara Cells 10 kDa Secretory Protein; OTTHUMP00000236107; SCGB1A1; Secretoglobin family 1A member 1; Secretoglobin, family 1A, member 1 (uteroglobin); UG; UGB; UP-1; UP1; Urinary Protein 1; Urine Protein 1; UTER_HUMAN; Uteroglobin; Utg.

Anti-Uteroglobin抗體,子宮珠蛋白抗體產(chǎn)品介紹：Uteroglobin belongs to the family of secretoglobins and is a secreted protein product of nonciliated bronchiolar Clara cells. There is convincing data suggesting it has phospholipase A2 inhibitory activity, as well as, a number of other immunomodulatory features including inhibition of interferon gamma signalling and Th1 vs. Th2 lymphocyte regulation. It was proposed as a potential peripheral marker of respiratory epithelial injury and bronchial dysfunction. Clara Cell Protein 16 concentrations have been determined in both serum and bronchoalveolar lavage fluid in numerous studies since 1994. In serum, its increase is associated with age, asbestos, nitrogen chloride and ozone exposure, sarcoidosis and high PEEP ventilation. Decreased serum CC16 levels are found after pulmonary resection, in silica-exposed workers, smokers and in asthma. Decreased CC16 concentrations were also found in the amniotic fluid of fetuses suffering from pulmonary hypoplasia caused by various mechanisms (diaphragmatic hernia, diabetic fetopathy, Turner and Down syndrome). In pleural effusions, the CC16 concentration appears to be associated with its diffusion from the lung as evidenced by high CC16 levels in cardiac pleural congestion.

抗體來(lái)源：本公司抗體有兔來(lái)源和鼠來(lái)源等

克隆類型：兔來(lái)源為多抗，鼠來(lái)源為單抗

產(chǎn)品類型：一抗

優(yōu)勢(shì)產(chǎn)品：

Anti-AFAP抗體,微絲相關(guān)蛋白1抗體
Anti-APC70抗體,轉(zhuǎn)錄激活蛋白crsp70抗體
Anti-APR3抗體,凋亡相關(guān)蛋白3抗體
Anti-C3orf15抗體,3號(hào)染色體開放閱讀框15抗體
Anti-ATP1抗體,血管緊張素激活蛋白1抗體
Anti-Adropin抗體,能量平衡相關(guān)蛋白抗體
Anti-AE2抗體,陰離子交換蛋白2抗體
Anti-Aconitase 1抗體,鐵調(diào)節(jié)蛋白1抗體
Anti-Apolipoprotein E抗體,載脂蛋白E抗體
Anti-AT2R2抗體,血管緊張素Ⅱ受體2抗體
Anti-ASH1L抗體,ASH1蛋白抗體
Anti-AKD1抗體,腺苷酸激酶結(jié)構(gòu)域蛋白1抗體
Anti-ACCN1抗體,腦鈉通道蛋白1抗體
Anti-Arginase 1抗體,*酶1抗體
Anti-Amisyn抗體,突觸融合結(jié)合蛋白6抗體
Anti-KAL1抗體,卡爾曼綜合癥基因1抗體
Anti-Mint3抗體,β淀粉樣前體蛋白結(jié)合蛋白3抗體
Anti-AMIGO1抗體,粘附分子IgG樣結(jié)構(gòu)域蛋白1抗體
Anti-ANTXR2抗體,炭疽毒素受體2抗體
Anti-ASTN2抗體,星形肌動(dòng)蛋白抗體